Druif zijde Een deel pioneer af pci lever munt Achternaam

Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter

New Perspectives in AF and PCI: Implications for the Practicing Physician. - ppt download

Xarelto® (rivaroxaban) – PIONEER

臨床藥學] PIONEER AF-PCI：心房顫動合併冠心症接受心導管治療，Rivaroxaban降低心導管後出血風險(Bleeding in Patients with AF Undergoing PCI) - NEJS

Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis | Open Heart

3 0 Patients undergoing PCI with atrial fibrillation AF

Frontiers | Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update

Atrial Fibrillation and PCI - ppt download

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review - ScienceDirect

RE-DUAL PCI™ vs PIONEER AF-PCI™

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy | Circulation

Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? | SpringerLink

Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI - The British Journal of Cardiology

How will PIONEER-AF change our practice? - ppt download

JCM | Free Full-Text | Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials

PIONEER AF-PCI Trial: Inclusion and Main Exclusion Criteria and Study... | Download Scientific Diagram

PIONEER AF-PCI Trial: Inclusion and Main Exclusion Criteria and Study... | Download Scientific Diagram

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status | tctmd.com

Studio PIONEER AF-PCI nei pazienti con fibrillazione atriale sottoposti ad angioplastica coronarica: quali risvolti clinici? - ATBV

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI | NEJM

Antithrombotic Strategy in Patients With AF and Recent ACS or PCI: Primary Results of the AUGUSTUS Trial - American College of Cardiology

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI | Challenges in Cardiology

Cureus | Trial Sequential Analysis Comparing Bleeding and Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation and Acute Coronary Syndrome on Dual versus Triple Therapy | Article

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet

PDF] Evaluation of the safety and efficacy of an edoxaban‐based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST‐AF

PIONEER AF-PCI Trial: Inclusion and Main Exclusion Criteria and Study Design | Radcliffe Cardiology